Giovanni Caforio has been appointed chief operating officer at Bristol-Myers Squibb and elected to the company's board of directors.


Bristol-Myers Squibb, Giovanni Caforio, chief operating officer, chief commercial officer, Lamberto Andreotti, James Cornelius












































































































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Supplier News Breaks

Bristol-Myers Squibb promotes exec to COO

June 9th, 2014

NEW YORK – Giovanni Caforio has been appointed chief operating officer at Bristol-Myers Squibb and elected to the company's board of directors.

Bristol-Myers said Monday that Caforio, previously chief commercial officer, will continue to report to chief executive officer Lamberto Andreotti.

In addition to his current duties as chief commercial officer, Caforio will add leadership responsibility for the companywide functions of enterprise services and global manufacturing and supply.

"Giovanni has contributed significantly to the success of the company, most recently building an integrated commercial organization supporting the company's evolution to a diversified specialty biopharma company," Andreotti commented. "Giovanni brings valuable experience to the role, from his training as a physician to his strong record in key leadership positions in marketing and operations in Europe, the U.S. and commercial. I am very proud of Giovanni's appointment to the board of directors, a tremendous honor that recognizes his commitment and contributions to our company."

Caforio joined Bristol-Myers in 2000 as vice president and general manager, Italy, and assumed leadership roles for Greece, South East Europe. In 2004, he was appointed senior vice president of European marketing and brand commercialization. Bristol-Myers noted that from 2007 to 2011, he helped build the company's leadership in immuno-oncology while directing U.S. and global oncology, as well as made key contributions as U.S. president and chief commercial officer from 2011 to 2014.

Before joining Bristol-Myers, Caforio spent 12 years with Abbott Laboratories in various leadership positions.

"Giovanni has been an integral leader for Bristol-Myers Squibb as the company has executed its biopharma strategy,” added chairman James Cornelius. "I look forward to his continued contributions to patients, shareholders and employees as a member of the board of directors."

More Supplier News Breaks >>
Advertisement